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Ischemic stroke is associated with motor impairment and increased incidence of affec-
tive disorders such as anxiety/clinical depression. In non-stroke populations, successful
management of such disorders and symptoms has been reported following diet sup-
plementation with long chain omega-3-polyunsaturated-fatty-acids (PUFAs). However, the
potential protective effects of PUFA supplementation on affective behaviors after experi-
mentally induced stroke and sham surgery have not been examined previously. This study
investigated the behavioral effects of PUFA supplementation over a 6-week period follow-
ing either middle cerebral artery occlusion or sham surgery in the hooded-Wistar rat. The
PUFA diet supplied during the acclimation period prior to surgery was found to be associ-
ated with an increased risk of acute hemorrhage following the reperfusion component of
the surgery. In surviving animals, PUFA supplementation did not influence infarct size as
determined 6 weeks after surgery, but did decrease omega-6-fatty-acid levels, moderate
sickness behaviors, acute motor impairment, and longer-term locomotor hyperactivity and
depression/anxiety-like behavior.
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INTRODUCTION
Ischemic stroke affects 15 million people a year and is a lead-
ing cause of disability worldwide (1). Recovery after stroke is
associated with high incidences of behavioral and affective dis-
orders including anxiety and (2, 3) clinical depression (4), which
are commonly co-morbid (5, 6). In non-stroke affected popu-
lations, depressive disorder is associated with delirium (7, 8).
Delirium is also common following stroke (9). Anxiety, depres-
sion, and delirium all negatively influence recovery after stroke
(9, 10). Depressive disorder is also similarly closely linked to
inflammation related “sickness behaviors” (11). Sickness behav-
iors are defined as the normal, ubiquitous responses to infec-
tion seen in all animal species examined and bear close biolog-
ical resemblance to clinical depression (11). Sickness behaviors
usually suppress normal activities such as eating and drinking.
Thus to achieve the best prognostic outcome for stroke sur-
vivors, it is important to design better management regimes
for post-stroke affective disorders (4) and sickness behaviors in
general.
An alternative therapy for the generic treatment of depres-
sion (12), anxiety (13), and hyperactive symptoms (14) are long
chain omega-3 polyunsaturated fatty acids (n-3-LC-PUFA) and
in particular eicosapentaenoic acid (EPA; 20:5n-3) and docosa-
hexaenoic acid (DHA; 22:6n-3) (14). Many studies, however,
regarding the effectiveness of n-3-LC-PUFA in the treatment
of emotional and behavioral disorders have found inconsistent
results, and the number of studies is limited, indicating a need
for additional research (15). The influence of such n-3-LC-PUFA
supplementation on mood and behavioral disorders has not previ-
ously been investigated after stroke either in humans or in animals
after experimentally induced ischemia via middle cerebral artery
occlusion (MCAo).
n-3-LC-PUFAs are highly bioactive compounds, commonly
derived from dietary fish oil, and have anti-inflammatory effects
at optimal doses (12). n-3-LC-PUFAs have anti-thrombotic effects
(16) and contribute to reduced platelet coagulation (17). Accord-
ingly, some animal studies demonstrate that n-3-LC-PUFAs
increase bleeding after experimentally induced intracerebral hem-
orrhage (18). We are unaware of any research indicating a potential
risk of PUFA supplementation on bleeding after cerebral ischemia.
Conversely, a number of previous studies have demonstrated neu-
roprotective effects of n-3-LC-PUFAs after cerebral ischemia in
animal models (19–21). Thus, in the present study, we compared
the effects of diet (n-3-LC-PUFA supplementation to the basal
diet vs. basal diet) over the 6-weeks after surgery (either MCAo or
sham surgery) in rats. In particular we aimed to study the effects
of diet on surgically induced acute and longer-term motor and
sickness behaviors, including behaviors commonly interpreted
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to reflect excessive anxiety or depressive-like behaviors in the
rodent model.
We hypothesized that following MCAo surgery animals would
show reduced food and water consumption, compared to shams.
Additionally, we hypothesized that the n-3-LC-PUFA diet supple-
mented animals would show less reduction in food and water
consumption, and body weight post-surgery, compared to the
basal diet fed animals.
Acute inabilities to make co-ordinated motor movements have
regularly been reported in rats post MCAo (22, 23) and decrease
in response to neuroprotective agents (24–26). Thus, we hypoth-
esized that the n-3-LC-PUFA supplemented animals would also
show less acute MCAo related motor impairments on a battery of
widely used neurological impairment tests (22, 23) compared to
basal diet fed rats.
We hypothesized that hyperactive locomotor behaviors assessed
using the free exploration test, would not correlate with anxiety-
like behavior in this test, defined by percentage of emergence
time spent in the center of the open-field arena. Previous
authors have speculated that MCAo related changes in loco-
motion might arise from an inability to habituate to unfamil-
iar environments, possibly related to spatial mapping difficulties
induced by hippocampus cell death (27–30). Therefore, spatial
mapping abilities were assessed here using the spatial displace-
ment recognition test, which has previously been employed to
study spatial memory deficits post-stroke in the rodent model (28,
31–33).
We hypothesized that MCAo operated animals would show
more long-term stroke-related anxiety-like and hyperactive loco-
motor behaviors than sham operated animals (MCAo vs. Sham).
Finally, we hypothesized that after surgery animals supplemented
with n-3-LC-PUFA would show less long-term sickness or anxiety-
like and locomotor behaviors than basal diet fed animals (n-3-LC-
PUFA vs. Basal). Long-term was defined as occurring at 2, 4, or
6 weeks following surgery.
In summary, we anticipated that n-3-LC-PUFA diet supple-
mentation would reduce acute MCAo related motor impairments,
and sickness behaviors. We expected the beneficial effects of
n-3-LC-PUFA diet supplementation to persist longer term, as
evidenced by a longer-term reduction in rodent behaviors, inter-
preted to reflect stroke-related behavioral and affective disorders.
MATERIALS AND METHODS
ANIMALS AND DESIGN
The experiment used two surgery groups (MCAo and Sham
groups) and two diet groups (basal and n-3-LC-PUFA supplemen-
tation) with repeated measures outcomes. Adult male hooded-
Wistar rats (Laboratory Animal Services, The University of Ade-
laide, Australia) commonly used in stroke research (34–36) were
separately housed (21± 2°C, 12:12 h light–dark cycle). Food and
water were available ad libitum and consumption and body weight
were measured daily. Acclimatization to housing and diet condi-
tion began 1 week prior to surgery and continued until animal
sacrifice (via isoflurane anesthesia; Cat No. AHN3640-250ML,
Baxter, Old Toongabbie, NSW, Australia) at 6 weeks post-surgery.
Animal behavior was studied until 6 weeks post-surgery as previ-
ous research, in non-stroke-related areas, has demonstrated that
6 weeks of oral supplementation with omega-3 is associated with
anti-depressive-like behavioral effects in rodent models (37). In
the week following surgery only, animals were provided with
sunflower seeds and soft food (Sustagen® Everyday Nestlé, Not-
ting Hill, VIC, Australia) additional to their respective diets, to
encourage eating and weight gain. Surgeries and behavioral test-
ing took place in the lights-on phase. The experimental protocol
required 48 animals;j however 11 rats in the n-3-LC-PUFA MCAo
group died immediately following withdrawal of the suture thread.
A further 16 rats (n-3-LC-PUFA MCAo, n= 7; Basal MCAo,
n= 9) were culled due to MCAo induced motor impairments
and clinical symptoms deemed too large for the animal to sur-
vive. These animals were replaced and thus, the total number of
animals used in the present study was 75 (n= 29 n-3-LC-PUFA
MCAo; n= 22 Basal MCAo; n= 12 n-3-LC-PUFA sham; n= 12
Basal Sham).
ETHICS STATEMENT
Ethics approval was granted by the Austin Health Research Ethics
Unit (10/3865) and was conducted in accordance with the Aus-
tralian Code of Practice for the use of animals for scientific
purposes (38).
DIETARY REGIME
Animals were randomly assigned to n-3-LC-PUFA diet condition
{Specialty Feeds, Cat No. SF09-109 5% Fat High N3 Modified
Rodent Diet, Glen Forest, WA, Australia [EPA 20:5 n-3 5% of total
free fatty acid (FFA), DHA 22:6 n-3 23.8% of total fatty acids]},
selected as it has previously been demonstrated to reduce oxida-
tive stress in the rat model (39) or basal diet condition (Specialty
Feeds, Cat No. AIN93G; Glen Forest, WA, Australia).
RIGHT MIDDLE CEREBRAL ARTERY OCCLUSION
Within each diet condition, animals were randomly assigned to
MCAo or sham surgery condition. Surgeries were performed
according to the protocol of Longa (40) and its modifications
by Spratt (41). Briefly, anesthesia was induced (5% in oxygen)
and maintained (2% in oxygen) with Isoflurane via a nose cone.
Vital signs were monitored using iWORX (Cat No. PO2-300D,
iWORX, Dover, NH, USA). Body temperature was maintained at
37°C. Atropine (0.2 ml 600µg/ml, Pfizer Australia Pty Ltd., NSW,
Australia) was administered intraperitoneally to inhibit bronchial
secretions and salivation. Cerebral blood flow was measured using
laser doppler flowmetry (LDF). The scalp was thinned using a
dental burr and the Laser Dopler was attached to a laboratory-
made rubber probe holder attached to skull with instant adhesive
(Loctite 406 instant adhesive, Cat No. 265606, Henkel, Sydney,
NSW, Australia). An incision was made in the neck, small branch-
ing blood vessels were cauterized, the external carotid artery was
ligated, an incision made in the right external carotid artery, a
0.4-mm diameter silicone tipped suture thread inserted into the
incision, passed via the right external carotid and up the internal
carotid artery. MCAo was 90 min during which incisions were
closed (4.0 silk sutures, Cat No. 90352, Dynek Pty Ltd., Port
Adelaide, SA, Australia) and animals were removed from anes-
thesia. For reperfusion, animals were re-anesthetized, incisions
re-opened and the MCA-occluding suture retracted. Vital signs
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and during reperfusion were monitored using iWORX (Cat No.
PO2-300D, iWORX, Dover, NH, USA). Animal breathing was
also monitored. Animals that died during the surgical or after
the reperfusion procedure, or within the first 24 h after surgery,
were documented and post mortem autopsy was conducted to
determine cause of death. Hemorrhage was determined at the
time of autopsy, by the presence of blood pooled around the
base of skull. Analgesia was provided as paracetamol (Cat No.
569925, Sanofi-Aventis, Macquarie Park, NSW, Australia) crushed
and dissolved into drinking water (0.15 mg/ml water). Saline was
injected (i.p.) daily for 3 days following surgery [3 ml Sodium
Chloride Solution (0.9%), Cat No. 7647-14-5, Tocris Bioscience,
Bristol, UK]. Sham animals underwent identical procedures with
the exclusion of thread insertion into the MCA. Table 1 displays
animal groups, final successful numbers, and behavior testing
timetable.
ACUTE STROKE-RELATED MOTOR IMPAIRMENT MEASURES
Motor impairments were assessed daily in the first 5 days post-
surgery using the forelimb flexion test [MCAo affected rats hold
left forelimb between 45° and 90° when lifted from base of tail (22)]
the torso twisting test [MCAo affected rats show curling of the head
and forelimbs toward the paralytic side of the body, when held via
tail (22)] the lateral push test [MCAo affected rats show weakened
resistance when pushed toward the paralytic left side (22)] and the
circling [animals with infarct damage circle toward the opposite
side of the damage (22)] and motor ability, observations (walk-
ing, grooming, and rearing behaviors) which collectively measure
the acute inability to make co-ordinated motor movements, reg-
ularly been reported and studied in rats post MCAo compared to
sham surgery (22, 23). These motor impairments are less severe
in animals exposed to neuroprotective agents (24–26), thus, we
aimed to determine if acute motor disability was decreased after
n-3-LC-PUFA supplementation.
LONGER-TERM ISCHEMIA ASSOCIATED BEHAVIORAL AND AFFECTIVE
DISORDERS
The battery of behavioral tests designed to model ischemia-related
affective behaviors were administered and recorded on video in
the second, and then repeated in the fourth and sixth weeks post-
stroke. The same animals were tested at each time point. Behavior
video was scored by an observer (NC) who was blind to ani-
mal diet and surgery condition. Animal behaviors were scored
by a second observer (MP), and the inter-rater reliability correla-
tion was statistically significant, r2= 0.97. To test for longer-term
sickness behaviors and particularly depression and anxious like
behaviors after surgery, we used the novel object exploration test
and a modified open-field test that measures the conflict between
a rat’s mutual drives to both avoid and approach unfamiliar and
potentially fear inducing stimuli/environments (32, 42–47). To
asses the locomotor hyperactivity often reported from as early
as 5 min to 5 weeks after MCAo surgery (29, 30, 48, 49) and in
rodent models of anxiety and depression (50–54), we used a mod-
ified free exploration test, which eliminates the forced exploration
and related stress normally associated with the commonly used
open-field test (55, 56). All behavior was recorded using a digital
camcorder (Canon Legria, HG20) and was stored as a MPEG-TS
video file. All apparatus were cleaned with 70% ethanol between
trials (Cat No. EA043-10L, Chem-Supply, Gillman, SA, Australia).
FREE EXPLORATION TEST
Animals were habituated (15 min) to a laboratory constructed
black Plexiglass hide box (30 cm× 15 cm× 19 cm) the day prior
and re-acclimated (5 min) immediately prior to testing. The
open field was a transparent Plexiglass arena (1 m2) illuminated
(~500 lux). The hide box was positioned inside one wall of the
open field. Animals were scored for locomotor hyperactivity
(number of times fully emerged from the hide box, i.e., emer-
gence number) and time spent fully emerged from hide box and
Table 1 | Experimental timeline showing order and timing of treatment and testing.
Animal surgery
and diet group
MCAo surgery and
n-3-LC-PUFA diet
MCAo surgery and
basal diet
Sham surgery and
n-3-LC-PUFA diet
Sham surgery and
basal diet
1 week prior to
surgery
Diet/housing acclimation Diet/housing acclimation Diet/housing acclimation Diet/housing acclimation
Surgery Surgery Surgery Surgery
Day 1–5
post-surgery
Acute motor impairment
testing
Acute motor impairment
testing
Acute motor impairment
testing
Acute motor impairment
testing
2 weeks
post-surgery
Free exploration, spatial
displacement recognition, and
novel object exploration testing
Free exploration, spatial
displacement recognition, and
novel object exploration testing
Free exploration, spatial
displacement recognition, and
novel object exploration testing
Free exploration, spatial
displacement recognition, and
novel object exploration testing
2 weeks
post-surgery
Behavioral testing as specified
in week 2 post-surgery
Behavioral testing as specified
in week 2 post-surgery
Behavioral testing as specified
in week 2 post-surgery
Behavioral testing as specified
in week 2 post-surgery
6 weeks
post-surgery
Behavioral testing as specified
in week 2 post-surgery
Behavioral testing as specified
in week 2 post-surgery
Behavioral testing as specified
in week 2 post-surgery
Behavioral testing as specified
in week 2 post-surgery
Sacrifice Sacrifice Sacrifice Sacrifice
MCAo, middle cerebral artery occlusion surgery condition; Sham, Sham surgery condition; Basal, basal diet fed rats; n-3-LC-PUFA, polyunsaturated fatty acid
supplemented rats.
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moving around the arena (emergence duration) for 4 min. Given
that the MCAo procedure and the associated neurodegenerative
damage result in increased locomotor, activity per se (29, 30, 48,
49) we suggest that the above-mentioned measures may not reflect
anxiety-like behaviors in MCAo operated animals, but instead may
only be another measure of locomotion hyperactivity. Animals
were however also scored for anxiety-like behavior that was defined
as the avoidance of the center and quantified as the percentage of
time spent in the center area also.
SPATIAL DISPLACEMENT RECOGNITION
Animals were acclimated (5 min) to the testing box (40 cm×
40 cm× 60 cm) the day prior to testing. On the day of testing,
animals were placed in the testing box, positioned with their nose
facing the mid-point of the wall opposite the objects, to prevent an
unintentional bias of placing the animal in an orientation favoring
a particular object (57). Object contact was defined as when the
mouth, nose, and/or paw touched the object or when the nose of
the rat was within 1 cm surrounding the object. Contact judged
as accidental, such as bumping the object as the animal passed
or grooming behavior was not counted. The number of object
contacts and the duration of these were recorded.
The spatial displacement recognition testing consisted of two
habituation trials (3 min each) to two identical objects. Habitua-
tion trials were separated by a 2-min interval, during which the
animal was returned to the home cage. The location of one of
the two objects was then moved and the animal was placed in the
testing box for a single 3 min recognition trial.
NOVEL OBJECT EXPLORATION
The novel object exploration trial took place immediately after the
spatial displacement recognition trial, separated only by a 2-min
interval (animal returned to home cage). Testing took place in the
same box used for the spatial displacement recognition test. Rats
were placed in the testing box for a single 3-min trial. The familiar
object was placed in one corner of the box and the novel object
was placed in the opposite corner. Object placement and selection
were counterbalanced across trials and animals. Contact definition
is consistent with that described above for the spatial displacement
recognition test.
TISSUE COLLECTION
Tissue was collected using two methods: (a) whole brain for total
FFA analysis (n= 5 n-3-LC-PUFA MCAo; n= 6 Basal MCAo;
n= 6 n-3-LC-PUFA Sham; n= 6 Basal Sham) animals were anes-
thetized via Isoflurane overdose, decapitated via guillotine, brains
removed, snap frozen in liquid nitrogen (Liquid Nitrogen Ser-
vices Pty Ltd., Melbourne, VIC, Australia), and stored at−80°. (b)
Perfusion for infarct analysis (n= 6 n-3-LC-PUFA MCAo; n= 6
Basal MCAo; n= 6 n-3-LC-PUFA Sham; n= 6 Basal Sham). Once
anesthetized, the rib cage and diaphragm were cut, a perfusion
needle placed into the left ventricle of the heart and the right
atrium cut. Saline (90 ml) (1.8%) was infused (5 min), followed
by paraformaldehyde (PFA) (4%) (270 ml) (15 min), using a per-
fusion pump (Peri-Star Pro 4-channel, high rate pump, Cat No.
PERIPRO-4HS, World Precision Instruments, Hilton, SA, Aus-
tralia) (18 ml/min). Brains were removed and placed directly into
PFA (4%) for 24 h, before being changed to 30% sucrose, where
they remained until the time of paraffin embedding.
FATTY ACID ANALYSIS
To confirm that the n-3-LC-PUFA supplementation resulted
in changes in brain phospholipids levels of fatty acids, whole
brain frozen tissue was ground up, and tissue lipids extracted
by dichloromethane/methanol (2:1) overnight, as described by
Sinclair et al. (58). Samples were filtered, saline added (1 ml of
0.9%), and vortexed (1 min). Samples were centrifuged (1500× g,
10 min) to separate the aqueous and organic phases at room tem-
perature. The organic phase containing the lipid was removed
and transferred to a new glass tube and evaporated under a
stream of nitrogen. The lipid extract was reconstituted in 200µl
of dichloromethane and lipids were then separated by thin layer
chromatography (TLC). The lipid extracts were spotted onto sil-
ica gel plates (silica gel 60 G, Merck, Germany) and developed
in 85:15:2 (v/v) petroleum ether: diethyl ether: acetic acid in
paper-lined tanks. The lipids were visualized with 0.1% (w/v)
2′,7′-dichlorofluorescein indicator in ethanol (Scharlau, Spain).
The phospholipid bands from the samples were scraped off into
glass screw-capped tubes and were reacted with 5% H2SO4 in
100% methanol (3 h at 80°C) to form the fatty acid methyl esters
(FAMEs). FAME were isolated (100% petroleum ether) and stored
in glass (−20°C). Purified FAME were isolated and identified using
an Agilent Technologies 7890A GC System (Agilent Technologies,
Santa Clara, CA, USA) equipped with an Omegawax 250 cap-
illary column (30 m× 0.25 mm internal diameter, 0.25µm film
thickness, Supelco, Bellefonte, PA, USA), a flame ionization detec-
tor (FID), an Agilent Technologies 7693 auto sampler, and a split
injection system (split ratio 50:1). The injection volume was 1µl,
the injector and detector temperature were 300 and 270°C, respec-
tively. The temperature program was 50–190 at 20°C min−1, then
from 190 to 250 at 4°C min−1, and held at 250°C for 8 min. The
carrier gas was helium at 1.18 ml min−1, at a constant flow. Each of
the fatty acids was identified relative to known external standards
(a series of mix and individual standards from Sigma-Aldrich,
Inc., St. Louis, MO, USA and from Nu-Chek Prep Inc., Elysian,
MN, USA). The resulting peaks were then corrected by the theo-
retical relative FID response factors (59) and quantified relative to
the internal standard.
INFARCT VOLUME ANALYSIS AND AREA OF DAMAGE
Brains were cut (2 mm coronal sections) using an acrylic rat brain
matrix. Tissue was processed using a closed linear Tissue Process-
ing System (Cat No. TPC 15, MEDITE GmbH, Wollenweberstr,
Burgdorf, Germany). Tissue was embedded in molten paraffin
wax (Cat No. Leica EG1150 H, Leica-microsystems, Ernst-Leitz-
Straße,Wetzlar,Germany), and stored at room temperature. Tissue
was cut at room temperature (7µm) using a rotary microtome
(Cat No. Leica 2040, Leica-microsystems, Ernst-Leitz-Straße, Wet-
zlar, Germany) suspended at 40°C in a tissue flotation bath and
attached to silane coated slides (Cat No. CS2460100MK, Micro-
glass, Grale Scientific, Melbourne, VIC, Australia). Tissue slides
were dried at 49°C, incubated at 32°C for 24 h, and stained with
Hematoxylin (5 g Hematoxylin; Cat No. 340374T, VWR Interna-
tional Pty Ltd., Murarrie, QLD, Australia) and Eosin (10 g Eosin Y;
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Cat No. E-4382, Sigma-Aldrich, St. Louis, MO, USA). Slides were
de-waxed in Histosol (Cat No. CP L HISTOSOL 08, HD Scien-
tific, Wetherill Park, NSW, Australia), washed in ethanol, rinsed
in dH2O, dehydrated in ethanol, followed by two Histosol washes.
Slides were rehydrated in ethanol rinsed in dH2O and stained with
filtered Harris Hematoxylin. Slides were rinsed in dH2O, stained in
filtered Eosin Y, washed in dH2O, and dehydrated in ethanol. This
was followed histosol washes and cover slipping (DPX, Cat No.
1019790500, Merck KGaA, Darmstadt, Germany). Stained tissue
was examined and using bright field microscopy (Nikon Eclipse
80i, Nikon Instruments Europe) with a Nikon DIGITAL SIGHT
DS-U1 camera. Photographs were stored as JPEG Image files. Areas
of tissue damage were analyzed using Stereo Investigator Version
6 software.
DATA ANALYSIS
The present study uses both parametric and non-parametric data
analysis techniques as appropriate. This study consists of four
independent groups [2× 2 (n-3-LC-PUFA MCAo; Basal MCAo;
n-3-LC-PUFA sham; Basal Sham)] and has both single time point
and repeated measures outcomes. Where data met the assump-
tion of normality, appropriate ANOVAs, as described below are
used. All measures of longer-term behavioral outcomes however
did not meet the assumption of normality and were unable to be
transformed (except spatial displacement recognition) and thus
non-parametric data analyses techniques have been used. It is
important to note however, that IBM SPSS Statistics does not offer
a non-parametric equivalent to the mixed design ANOVA (the
appropriate parametric analysis technique to analyze the longer-
term behavioral outcome data). The non-parametric Friedman’s
ANOVA allows a comparison of two or more related groups, but
is not appropriate for the current study, where groups are inde-
pendent. The Kruskal–Wallis is appropriate for the current data,
as it allows one to compare differences between two or more
independent groups (i.e., n-3-LC-PUFA MCAo vs. Basal MCAo/n-
3-LC-PUFA sham vs. Basal Sham) (60). To determine where group
differences exist, Mann–Whitney post hoc tests were used. In order
to control for type 1 errors, only the most important/relevant
post hoc Mann–Whitney comparisons were made, thus differences
between diet groups; within each of the different surgery condi-
tions, at weeks 2, 4, and 6 post-surgery, have not been assessed.
We determined that the most important/relevant post hoc Mann–
Whitney comparisons are: (a) differences between MCAo operated
and Sham operated rats and (b) differences between n-3-LC-PUFA
and basal diet fed rats, at weeks 2, 4, and 6 post-surgery, and thus
these group differences have been assessed.
For single time point outcome measures, where the assump-
tions of normality were met [infarct volume and total fatty acid
levels (micrograms) in brain phospholipids] ANOVAs were con-
ducted. For outcome variables measured at multiple time points
[body weight, food, and water consumption (grams), acute stroke-
related motor impairment and spatial displacement recognition]
mixed design ANOVAs were conducted (effect of diet condition
within surgery condition measured at multiple time points). LSD
post hoc test with a Bonferroni correction were used. Normality
of data from behavioral tests was assessed using Q-Q plots and
histograms. Outliers were screened for using box plots and no
data was deleted, the assumptions of homogeneity was checked
using Levene’s Test of Equality of Variance, and sphericity was
checked using Mauchly’s Test of Sphericity. A square root transfor-
mation was conducted on spatial displacement recognition data to
achieve a normal distribution. Spearman correlations were used to
detect correlations between emergence behavior and infarct dam-
age. Spearman correlations were also conducted between both the
number of emergences from the hide box into the open field and
the duration of time spend moving around the open-field arena,
and the percentage of emergence time spent in the center of the
open-field arena. Independent sample t tests were used to com-
pare mean differences in animal weight and the number of animals
that died from hemorrhage following the reperfusion component
of the surgery, as reported below, between diet groups at time of
surgery.
RESULTS
USING PARAMETRIC DATA ANALYSIS TECHNIQUES
Increased risk of reperfusion related hemorrhage following
reperfusion among n-3-LC-PUFA supplemented animals
An unexpected finding of the present research that has not previ-
ously been reported was that 39% (N = 11) of all the n-3-LC-
PUFA diet acclimated animals that underwent MCAo surgery
experienced subarachnoid hemorrhagic bleeding following the
reperfusion component of the surgery, as illustrated in Figure 1.
Upon unblinding of groups, we found that this surgical compli-
cation was only seen in the n-3-LC-PUFA diet acclimated animals
and did not occur in any of the basal diet fed rats. We did note any
intracerebral bleeding in animals in either of the diet groups. Inde-
pendent sample t tests indicate that the difference in the rate of
reperfusion related bleeding between diet groups was significant,
t (17)= 3.29, p< 0.01. These animals were obviously excluded
from the final cohort numbers. A further 16 rats who did not
experience hemorrhagic bleeding were culled after surgery, due to
MCAo symptoms too large for the animal to survive. All these rats
were replaced and thus the total number of animals used in the
present study was 75 (n= 29 n-3-LC-PUFA MCAo; n= 22 Basal
MCAo; n= 12 n-3-LC-PUFA sham; n= 12 Basal Sham). Unfortu-
nately, as the death of the n-3-LC-PUFA fed animals following the
reperfusion component of the surgery was unexpected we were
unable to prepare the tissue for further experimental analysis.
ANIMAL WEIGHT FROM TIME OF SURGERY UNTIL SACRIFICE
Surviving animal (N = 48) mean bodyweight was 337 (SD= 36.5)
grams at time of surgery. There was no main effect for
diet condition in mean bodyweight at time of surgery, F(1,
47)= 1.14, p= 0.29 (n-3-LC-PUFA M = 332, SE= 6.7, Basal
M = 342, SE= 6.4). Between surgery conditions, sham operated
rats were slightly lighter than MCAo operated animals, F(1,
47)= 14.24, p< 0.01 (MCAo M = 354, SE= 6.6, Sham M = 320,
SE= 6.6). There was no interaction between diet and surgery
condition on animal body weight at the time of surgery.
FOOD ANDWATER CONSUMPTION FROM TIME OF SURGERY UNTIL
SACRIFICE
Rats did not differ in food and water consumption at the time of
surgery (see Figures 2 and 3). On average at the time of surgery,
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FIGURE 1 | Number of MCAo operated rats that experienced
reperfusion related hemorrhage, between diet conditions. MCAo,
middle cerebral artery occlusion surgery condition; Basal, basal diet fed
rats; n-3-LC-PUFA, polyunsaturated fatty acid supplemented rats; n=11
n-3-LC-PUFA MCAo; n=0 basal MCAo.
FIGURE 2 | Mean food consumption (shown with confidence
intervals), between stroke and diet conditions from week 1 until week
6 post-surgery. MCAo, middle cerebral artery occlusion surgery condition;
Sham, Sham surgery condition; Basal, basal diet fed rats; n-3-LC-PUFA,
polyunsaturated fatty acid supplemented rats; week 1, week one
post-surgery; week 2, week two post-surgery; week 3, week three
post-surgery; week 4, week four post-surgery; week 5, week five
post-surgery; week 6, week six post-surgery. n=11 n-3-LC-PUFA MCAo;
n=13 Basal MCAo; n=12 n-3-LC-PUFA sham; n=12 Basal Sham.
sham operated n-3-LC-PUFA diet fed animals were consuming
~206 mg of EPA, and 909 mg of DHA per day, per kilogram of
total body weight. MCAo operated n-3-LC-PUFA diet fed rats
were consuming 181 mg of EPA and 800 mg of DHA per day, per
kilogram of total body weight.
FIGURE 3 | Mean water consumption (shown with confidence
intervals), between surgery and diet conditions from week 1 until
week 6 post-surgery. Note the large drop in water consumption
immediately after surgery and the rapid recovery in drinking behavior, by
week 2 post-surgery, and by the time that ischemia associated motor
impairments were no longer obvious. MCAo, middle cerebral artery
occlusion surgery condition; Sham, Sham surgery condition; Basal, basal
diet fed rats; n-3-LC-PUFA, polyunsaturated fatty acid supplemented rats;
week 1, week one post-surgery; week 2, week two post-surgery; week 3,
week three post-surgery; week 4, week four post-surgery; week 5, week
five post-surgery; week 6, week six post-surgery. n=11 n-3-LC-PUFA
MCAo; n=13 Basal MCAo; n=12 n-3-LC-PUFA sham; n=12 Basal Sham.
All animals increased in bodyweight from week 1 until week 6
post-surgery, F(59, 205)= 30.43, p< 0.01. Food, F(5, 215)= 5.79,
p< 0.01 and water, F(5, 220)= 13.10, p< 0.01 consumption
increased between week 1 and week 6 post-surgery. A main
effect of surgery condition was seen and as MCAo operated ani-
mals consumed less food from week 1 until week 6 post-surgery,
F(1, 43)= 25.46, p< 0.01 and drank less water, F(1, 44)= 4.40,
p< 0.05, than sham operated animals. A main effect of diet con-
dition was also seen over the same period of time, as n-3-LC-PUFA
supplemented animals consumed more food, F(1, 43)= 12.47,
p< 0.01, and water, F(1, 44)= 18.06, p< 0.01 than basal diet fed
rats. No interaction effects were seen.
During the 6-weeks post-surgery, sham operated n-3-LC-PUFA
diet fed animals consumed an average of 272 mg of EPA and
1200 mg of DHA daily, per kilogram of total body weight. On
average, MCAo operated n-3-LC-PUFA diet fed animals con-
sumed 189 mg of EPA and 833 mg of DHA daily, per kilogram
of total body weight. Figures 2 and 3 show the mean food con-
sumption in grams and mean water consumption in milliliters
respectively, between stroke and diet conditions, between week 1
and 6 post-surgery.
FATTY ACID ANALYSIS
Fatty acid levels are reported as percentage of total FAME. There
were no main effects of surgery condition on fatty acid levels.
ANOVA showed a main effect for diet condition of fatty acid levels,
as n-3-LC-PUFA fed animals showed less n-6 in whole brain tissue
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than animals fed the basal diet, evidenced by less arachidonic acid
(AA; 20:4, n-6), F(1, 23)= 8.01, p< 0.05, linoleic acid (LA; 18:2,
n-6), F(1, 23)= 37.41, p< 0.01 and palmitic acid (16:0) in brain
phospholipids, F(1, 23)= 5.51, p< 0.05. A trend for higher levels
of eicosatrienoic acid (ETA; 22:3, n-3), F(1, 23)= 3.85, p= 0.06,
among n-3-LC-PUFA fed rats than basal fed rats was seen. No
main significant main effect of diet was seen in the amount of
DHA (22:6, n-3), F(1, 23)= 0.30, p> 0.05, or EPA (20:5, n-3),
F(1, 23)= 0.72, p> 0.05. There were no significant interaction
effects. Figure 4 illustrates differences in the mean fatty acid levels
in the brain phospholipids between diet and surgery conditions.
INFARCT VOLUME ANALYSIS AND AREA OF DAMAGE
Mean volume (cubic millimeter) of damaged tissue between stroke
and diet conditions at week 6 post-surgery and an outline of infarct
area 6-weeks after MCAo, is illustrated in Figure 5. MCAo affected
animals showed a greater volume (cubic millimeter) of damaged
tissue, F(3, 20)= 21.82, p< 0.01 (M = 78.72, SE= 16.12) when
compared to sham operated animals that did not show any infarct
damage (M = 0.0, SE= 0.0). No main effect on infarct volume was
found for diet condition, F(3, 20)= 0.14, p> 0.05 (n-3-LC-PUFA,
M = 36.23, SE= 16.15; basal, M = 42.50, SE= 16.76). No signif-
icant interaction effects were seen. In MCAo operated animals,
FIGURE 4 | Mean percentage and confidence intervals of whole brain
phospholipid fatty acids in fatty acid methyl esters between diet and
surgery conditions. Note that although no difference between dietary
conditions is seen in the level of eicosapentaenoic acid (20:5) or
docosahexaenoic acid (22:6), the levels of fatty acids (palmitic acid [16:0],
arachidonic acid [20:4], and linoleic acid [18.2]) were higher in basal diet fed
animals, compared to n-3-LC-PUFA fed animals, in whole brain tissue. By
comparison, n-3-LC-PUFA fed animals are shown to express more omega-3
derived fatty acids [eicosatrienoic acid (22:3)] than basal diet fed animals. No
differences are seen in fatty acid methyl esters between surgery groups.
−20:5 n-3, eicosapentaenoic acid; 22:6 n-3, docosahexaenoic acid; 20:4 n-6,
arachidonic acid; 18:2 n-6, linoleic acid; 16:0, palmitic acid; 22:3 n-3,
eicosatrienoic acid. MCAo, middle cerebral artery occlusion surgery
condition; Sham, Sham surgery condition; Basal, basal diet condition;
n-3-LC-PUFA, n-3 L-C-PUFA enriched diet condition. *Denotes statistically
significant at p=0.05, **denotes statistically significant at p=0.01. n=11
n-3-LC-PUFA MCAo; n= 13 Basal MCAo; n= 12 n-3-LC-PUFA sham; n=12
Basal Sham.
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FIGURE 5 | Mean volume (cubic millimeter) of damaged tissue (shown
with standard error), between stroke and diet conditions at week 6
post-surgery and outline of infarct area 6-weeks after middle cerebral
artery occlusion. Variability was seen in infarct size and animals (n=5) with
smaller infarcts generally showed atrophy in the area 1 outline, animals with
larger infarcts (n=5) showed atrophy in the both area 1 and 2. (1) area of
atrophy in animals with smaller infarcts; (2) area of atrophy additional to area
A in animals with larger infarcts; A, motor areas M1 and M2; B,
somatosensory cortex; C, auditory cortex; D, caudate putamen; E, amygdala
region; F, ventral posterolateral thalamic nucleus/ventral posteromedial
thalamic nucleus; G, lateral hypothalamic area. *Denotes statistically
significant at p=0.05, **denotes statistically significant at p=0.01. n=11
n-3-LC-PUFA MCAo; n=13 Basal MCAo; n=12 n-3-LC-PUFA sham; n=12
Basal Sham.
right hemisphere infarct was seen in cortical and subcortical tissue.
Variability was seen in infarct size. The area labeled A in Figure 5
outlines the infarct region typically seen in animals with smaller
infarcts [n= 5 (n-3-LC-PUFA diet= 2)]. Both the areas labeled
A and B outline the infarct region seen in animals with medium
infarcts [n= 4 (n-3-LC-PUFA diet= 1)]. The areas outlined A,
B, and C outlines the infarct region seen in animals with larger
infarcts [n= 3 (n-3-LC-PUFA diet= 3)].
ACUTE STROKE-RELATED MOTOR IMPAIRMENT MEASURES
Main effects for surgery condition were found for all motor impair-
ment measures, with MCAo operated animals showing greater
impairment, forelimb flexion, F(1, 36)= 19.32, p< 0.01, torso
twisting, F(1, 35)= 40.29, p< 0.01, lateral push, F(1, 36)= 36.34,
p< 0.01,circling,F(1,35)= 52.52,p< 0.01 and motor ability,F(1,
36)= 23.04, p< 0.01. A significant main effect of diet condition
was seen for lateral push, F(1, 36)= 4.34, p< 0.05.
Interaction effects between diet and surgery condition were
seen for lateral push, F(1, 36)= 4.34, p< 0.05, and motor ability
F(1, 36)= 5.22, p< 0.05, with n-3-LC-PUFA MCAo operated rats
showing a smaller impairment than basal fed rats (lateral push:
MCAo Basal M = 0.20, MCAo n-3-LC-PUFA M = 0.10; motor
ability: MCAo Basal M = 0.40, MCAo n-3-LC-PUFA M = 0.20)
and sham exposed rats showing minimal impairment, irrespec-
tive of diet condition (lateral push: Sham Basal M = 0.0, Sham
n-3-LC-PUFA M = 0.0; motor ability: Sham Basal M = 0.0, Sham
n-3-LC-PUFA M = 0.05).
Repeated measures ANOVA showed a decrease in motor
impairment from day 1, until day 5 post-surgery. A statistically
significant main effect for days after surgery was seen in the
torso twisting test, F(3, 118)= 3.23, p< 0.05, lateral push test,
F(4, 144)= 3.01, p< 0.05, circling, F(4, 140)= 4.78, p< 0.01, and
motor ability observations, F(4, 144)= 5.65, p< 0.01.
LONGER-TERM ISCHEMIA ASSOCIATED BEHAVIORAL DISORDERS
Spatial displacement recognition – classically considered a test for
spatial memory deficits
No main effects were found for surgery condition, F(1, 44)= 0.14,
p= 0.71, or diet condition, F(1, 44)= 0.09, p= 0.77 at any test-
ing time point post-surgery. There were no interaction effects. All
animals were found to explore the displaced object equally.
NON-PARAMETRIC DATA ANALYSIS TECHNIQUES
Free exploration test – locomotor hyperactivity
Measures of locomotor hyperactivity were significantly correlated
with each other (rho= 0.82, p< 0.00), indicating that these two
outcomes are likely reflecting the same construct. Spearman corre-
lation showed a positive correlation between total infarct volume
and emergence number at weeks 2 (rho= 0.47, p< 0.05) and 6
(rho= 0.44, p< 0.05) and a trend at week 4 (rho= 0.39, p= 0.06).
Kruskal–Wallis non-parametric analysis showed that diet and
surgery groups differed in the number of full body emergences
from the hide box into the open field, at weeks 4 [H (3)= 7.81,
p= 0.05] and 6 [H (3)= 10.34, p< 0.05], and in the total dura-
tion spent emerged and moving in the open field at week 6
[H (3)= 10.00, p< 0.05]. Post hoc Mann–Whitney tests show that
MCAo affected animals made more emergences from the hide
box into the open field than sham affected animals at weeks
4, U = 179.5, z =−2.39, p< 0.05 (MCAo, mdn= 1, IQR= 2.75;
Sham, mdn= 0; IQR= 1) and 6, U = 155, z =−2.87, p< 0.01
(MCAo, mdn= 2, IQR= 3.5; Sham, mdn= 0; IQR= 1.75). Emer-
gence duration similarly differed between surgery groups at week
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6, U = 1.72, z =−2.48, p< 0.05 with MCAo animals (mdn= 145;
IQR= 177) spending more seconds emerged than sham (mdn= 8;
IQR= 116) affected animals, indicative of more stroke-related
locomotor hyperactivity. A comparison of diet conditions showed
that n-3-LC-PUFA animals (mdn= 15; IQR= 145) spent fewer
seconds out in the open-field area than basal fed rats (mdn= 95;
IQR= 189) at week 6 post-surgery, U = 195, z =−1.99, p< 0.05,
suggesting that n-3-LC-PUFA supplementation reduced locomo-
tor hyperactivity by 6 weeks post-surgery. Figures 6 and 7 depict
box plots showing significant post hoc differences between groups.
FREE EXPLORATION TEST – CLASSICALLY A TEST OF ANXIETY-LIKE
BEHAVIOR
The above outlined measures of locomotor activity were both
found to be negatively correlated with the percentage of total emer-
gence time spent in the center of the open-field arena [emergence
number (rho=−0.35, p< 0.01) and duration of time spent mov-
ing in the open-field arena (rho=−0.45, p< 0.01)], indicating
that they are unlikely to reflect anxiety-like behavior in operated
animals.
Non-parametric Kruskal–Wallis test indicated that surgery and
diet groups differed in the percentage of total emergence time
spent in the center of the open-field arena at 4 weeks post-surgery,
as compared to side wall of the arena, H (3)= 7.79, p< 0.05. At
6 weeks post-surgery, an effect for a difference in the percentage
of total emergence time spent in the center of the open field arena
FIGURE 6 | Box plots showing significant post hoc differences in
number of emergences into open field, between diet and surgery
conditions. Visual inspection of this Figure indicates that sham
surgery-operated animals were less active than MCAo operated animals
and that in each surgery condition, at each time point, the n-3-LC-PUFA
animals emerged from the hide box less often, suggesting less
hyperactivity. MCAo, middle cerebral artery occlusion surgery condition;
Sham, Sham surgery condition; Basal, basal diet fed rats; n-3-LC-PUFA,
polyunsaturated fatty acid supplemented rats. n=11 n-3-LC-PUFA MCAo;
n=13 Basal MCAo; n=12 n-3-LC-PUFA sham; n=12 Basal Sham.
approached significance, H (3)= 7.25, p= 0.06. The appropriate
post hoc Mann–Whitney test indicated that rats supplemented
with n-3-LC-PUFA spent significantly a greater percentage of total
emergence time in the center of the arena at week 4, U = 16.2.0,
z =−2.72, p< 0.01 (n-3-LC-PUFA, mdn= 66, IQR= 80; Basal,
mdn= 0; IQR= 51), and week 6, U = 161.5, z =−2.65, p< 0.01
(n-3-LC-PUFA, mdn= 70, IQR= 40; Basal, mdn= 40; IQR= 56),
compared to basal diet fed rats. Post hoc tests showed no differences
between surgery conditions. Figure 8 depicts box plots showing
significant post hoc differences between groups.
NOVEL OBJECT EXPLORATION – CLASSICALLY CONSIDERED A TEST OF
APPROACH AVOIDANCE BEHAVIORS
Approach–avoidance conflict was studied using the novel object
exploration test. Box plots are presented in Figure 9. Surgery and
diet groups differed in novel object exploration time at 4 weeks,
H (3)= 9.00, p< 0.01, and 6 weeks post-surgery, H (3)= 12.50,
p< 0.01.
Post hoc comparisons between surgery conditions showed
MCAo affected animals explored the novel object less (in sec-
onds) than sham operated animals at week 4 post-surgery,
U = 175, z =−2.32, p< 0.05 (MCAo, mdn= 6, IQR= 17; Sham,
mdn= 17; IQR= 42). Animals did not demonstrate any MACo
FIGURE 7 | Box plots showing significant post hoc differences in
emergence duration between diet and surgery conditions at 6 weeks
post-surgery. Visual inspection of this Figure indicates that sham
surgery-operated animals spent less time moving around in the open-field
arena compared to MCAo operated animals. Furthermore, in each surgery
condition, n-3-LC-PUFA diet fed animals spent less time moving around the
open-field arena than do basal diet fed animals. MCAo, middle cerebral
artery occlusion surgery condition; Sham, Sham surgery condition; Basal,
basal diet fed rats; n-3-LC-PUFA, polyunsaturated fatty acid supplemented
rats. n= 11 n-3-LC-PUFA MCAo; n=13 Basal MCAo; n=12 n-3-LC-PUFA
sham; n=12 Basal Sham.
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FIGURE 8 | Box plots showing significant post hoc differences in
percentage of total emergence time spent in center of open field,
compared to the side wall of the open-field arena, between diet and
surgery conditions. Visual inspection of this figure indicates that
n-3-LC-PUFA diet fed animals spent more time in the center of the arena,
than did basal diet fed animals. No effects of surgery condition on
percentage of time spent in the center of the arena can be seen. MCAo,
middle cerebral artery occlusion surgery condition; Sham, Sham surgery
condition; Basal, basal diet fed rats; n-3-LC-PUFA, polyunsaturated fatty acid
supplemented rats. n=11 n-3-LC-PUFA MCAo; n=13 Basal MCAo; n=12
n-3-LC-PUFA sham; n=12 Basal Sham.
related motor deficits that might have been responsible for changes
in exploration behaviors. Post hoc comparison of diet conditions
showed that the n-3-LC-PUFA supplemented animals in each
surgery condition spent more significantly more seconds explor-
ing the novel object than the basal fed animals at week 6, U = 144,
z =−2.95, p< 0.01 (n-3-LC-PUFA, mdn= 31, IQR= 23; Basal,
mdn= 14; IQR= 15). At weeks 4, an effect for greater exploration
of the novel object by n-3-LC-PUFA supplemented animals com-
pared to basal diet fed animals approached significance, U = 198,
z =−1.85, p= 0.06 (n-3-LC-PUFA, mdn= 17, IQR= 28; Basal,
mdn= 5; IQR= 18).
DISCUSSION
We aimed to investigate effects of on-going n-3-LC-PUFA supple-
mentation on surgery induced sickness behaviors, motor impair-
ment, and anxiety-like and locomotor behaviors. To our knowl-
edge, this is the first rodent study to explore the effects of n-
3-LC-PUFA supplementation against persistent anxiety-like and
locomotor behaviors post-surgery.
Surprisingly, increased reperfusion related hemorrhagic risk in
MCAo n-3-LC-PUFA supplemented rats occurred, even after only
a short acclimation period (1 week prior to surgery). Thus, while
n-3-LC-PUFA supplementation may reduce affective and behav-
ioral disorders, it also appears to be associated with increased risk
FIGURE 9 | Box plots showing significant post hoc differences in time
spent exploring novel object exploration between diet and surgery
conditions both at 4 and 6 weeks post-surgery. Visual inspection of this
figure indicates that at both time points sham surgery-operated animals
supplemented with n-3-LC-PUFA diet spent more time exploring the novel
object than sham operated basal diet fed animals. MCAo surgery-operated
animals supplemented with n-3-LC-PUFA diet appear to have spent slightly
more time exploring the novel object than MCAo operated basal diet fed
animals. MCAo, middle cerebral artery occlusion surgery condition; Sham,
Sham surgery condition; Basal, basal diet fed rats; n-3-LC-PUFA,
polyunsaturated fatty acid supplemented rats. n=11 n-3-LC-PUFA MCAo;
n=13 Basal MCAo; n=12 n-3-LC-PUFA sham; n=12 Basal Sham.
of hemorrhagic bleeding. Unfortunately, the death of the n-3-
LC-PUFA fed animals following the reperfusion component of
the surgery was unexpected, we were unable to rescue the tissue
for further experimental analysis, and thus, this preliminary data
should be interpreted with caution.
As far as we are aware, n-3-LC-PUFA related hemorrhagic
bleeding has not previously been reported in the context of experi-
mental MCAo. Our findings are consistent however with previous
rodent studies, using an experimental model of intracerebral hem-
orrhage. One study demonstrated that 41% of animals died due
to excessive bleeding after experimentally induced intracerebral
hemorrhage, when fed a diet supplemented with 1% EPA/DHA,
for a period of 5 weeks prior to surgery. The authors concluded that
the increased mortality might be due to DHA and EPA associated
increases in oxidative damage (18). Indeed, FFA expression is seen
to increase at 7 days after experimentally induced hemorrhagic
stroke in rodents, with expression returning to baseline levels at
14 days post-surgery (61). Another study indicated that 2 weeks of
supplementation with fish oil (9% DHA and 12.9% EPA) prior
to intracerebral hemorrhage, is associated with increased cerebral
blood flow in the peri-infarct region and contralateral hemisphere,
at 6 h after surgery, in male Sprague-Dawley rats. Animals fed the
fish oil diet also showed greater disability in fine motor control,
compared to animals fed a sunflower oil enriched diet (rich in
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omega-6). The above-mentioned disabilities were present in spite
of no statistically significant difference in infarct size, between
animals in different diet groups (62). A second study indicated
high omega-6 AA was negatively associated with gastric hemor-
rhage, and that 7 days of fish oil supplementation decreases AA
in liver phosphatidylcholine. Those authors speculated that fish
oil may increase gastric bleeding due to modulating the perme-
ability of cell membranes in the gastric mucosa (63) in their
inbred rats that were fed a 7.5% fish oil diet. Given the limited
research, we are unable to specify if hooded-Wistar rats differ
in bleeding times, rates of platelet aggregation, and responsive-
ness to dietary EPA/DHA supplementation compared to other rat
strains. After subarachnoid hemorrhage, both animal and clinical
studies demonstrate that EPA reduces vasospasm, or contrac-
tion of smooth muscle cells, in part via inhibition of TXA2, a
thromboxane that increases platelet aggregation. Conversely, the
F2-isoprostanes, derived from the omega-6 fatty AA, are asso-
ciated with increased risk of subarachnoid hemorrhage related
vasospasm (64–69).
In Greenland Eskimos, high PUFA consumption has long been
associated with increased incidence of hemorrhagic stroke (70,
71). In clinical populations, a small study involving 20 individuals,
demonstrated that PUFAs expression is elevated in the cerebral
spinal fluid (CSF) of individuals who experienced hemorrhagic
stroke, at 24 until 48 h after insult, when compared to non-stroke
affected individuals (67). A later clinical study by the same authors,
involving 25 patients, who experienced either hemorrhagic or
ischemic stroke, similarly showed elevated PUFA expression in
CSF, within 48 h following insult, compared to healthy individuals
(72). Additionally, PUFA expression was positively correlated with
worse outcome at the time of hospital discharge. The authors inter-
preted these data to indicate the PUFA expression may be a marker
of stroke outcome. These authors however found no difference in
PUFA expression between individuals who experienced a hemor-
rhagic stroke compared to those who experienced ischemic stroke
(72). Animal studies have also documented elevated PUFA expres-
sion after ischemic stroke (73–75) and thus the role of PUFAs in
hemorrhagic stroke specifically is still unclear.
Stroke survivors are already considered particularly high risk
for hemorrhagic transformation (76–79). Therefore, some authors
argue that it is prudent to ensure that patients who are classified
as high risk for hemorrhage discontinue n-3-LC-PUFA consump-
tion (80). Other authors claim that fish oil consumption is not
dangerous in clinical populations (16) and that the empirically
supported benefits of PUFA supplementation simply outweigh
the yet unproven potential hemorrhagic risks (16). In humans, fish
oils do not appear to decrease platelet aggregation (81) or platelet
derived growth factor (82). Even when taken in conjunction with
other blood thinning agents, such as aspirin and warfarin, fish oil
consumption appears to have no significant effect on bleeding (83–
85). Harris reviewed 19 studies involving individuals taking fish oil
after percutaneous transluminal coronary angioplasty, coronary
artery bypass grafting, endarterectomy or coronary angiography,
and concluded that fish oil supplementation does not increase
clinically significant bleeding, and concluded that PUFAs do not
appear to affect bleeding (86). It should be noted however, that
none of the studies reviewed, investigated the effect of bleeding in
relation to cerebral ischemic or hemorrhagic stroke (86). Con-
versely, an earlier review by Knapp concluded that, while evi-
dence is inconsistent, that polyunsaturated fatty acids do appear
to increase template bleeding time in human populations (87).
Additionally, a number of clinical studies that have investigated
the effects of fatty acids after subarachnoid hemorrhagic stroke,
suggest that the omega-3 fatty acid EPA inhibits vasoconstriction,
while the omega-6 AA, contributes to vasospasm. Thus, in the case
of subarachnoid hemorrhagic, fatty acids do appear to influence
blood flow in clinical populations (64–69).
Research investigating the neuroprotective effect of n-3-LC-
PUFAs after ischemic stroke, typically begin n-3-LC-PUFA admin-
istration after the surgical procedure (19, 21). In the present
research, supplementation commencing after surgery was not
appropriate, as we were interested in monitoring sickness behav-
ior post-surgery, and changing the diet after surgery was likely to
confound eating behaviors. However, given the increased hem-
orrhagic bleeding seen in the present study, we suggest that pre-
feeding with n-3-LC-PUFA may be dangerous (16, 17, 76–80).
Further research is required to clarify the potential risks of n-3-LC-
PUFA supplementation on hemorrhagic bleeding in vulnerable
populations (62, 63).
Prolonged changes and decreases in eating and drinking behav-
iors are a feature of sickness behaviors in animals (88). Therefore,
it is not surprising that sham animals had higher food and water
intake than MCAo affected animals post-surgery. As hypothe-
sized, n-3-LC-PUFA supplemented animals similarly consumed
more water than basal fed rats post-surgery. Our unpublished
data shows non-surgery affected, normally reared, n-3-LC-PUFA
supplemented rats, do not consume more food and water than
basal diet fed rats. Therefore, it is unlikely that n-3-LC-PUFA fed
animals drink more due to increased salt or dietary change. In
the present study increased water consumption among n-3-LC-
PUFA supplemented rats after surgery could reflect better recovery
from surgery, as animals rapidly replace surgery associated blood
volume loss.
Not surprisingly, MCAo affected animals showed acute motor
impairment in the 5-days following surgery. However, as motor
impairment scores in the first 5 days following MCAo did not
correlate with infarct size as determined at 6 weeks post-surgery,
indicating that early motor impairments is more likely to reflect
short term MCAo related ischemia and associated edema rather
than longer-term tissue atrophy. Thus, the motor impairment tests
used in the present study are not appropriate measures of MCAo
related cellular damage in rodents.
MCAo affected animals showed increased locomotive behav-
iors compared to sham operated animals, which is consistent
with previous research (89). Previous authors have speculated
that MCAo related locomotor deficits might arise from an inabil-
ity to habituate to unfamiliar environments, possibly related to
spatial mapping difficulties induced by hippocampus cell death
(27–30). However, the present research does not indicate “habit-
uation” deficits in ischemia-affected animals, as we found no
difference between stroke and sham affected animals in the spatial
displacement recognition test at 2, 4, and 6 weeks, post-surgery.
It is possible that ischemia associated cell proliferation in the
hippocampus may have already occurred by the time the first
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spatial displacement recognition test was conducted, at 2 weeks
post-surgery, and corrected any spatial mapping disabilities that
may have been previously present. Indeed, MCAo associated hip-
pocampal neuronal degeneration is seen to peak between 12 h and
7 days after surgery, with no further degeneration after this point,
in rodents (90). Additionally, neurogenesis in the adult hippocam-
pus is seen to increase eightfold 1 week after focal ischemia, but
return to basal levels 2 and 3 weeks post insult (91). After tran-
sient ischemia CA1 neurons are seen to completely repopulate
by 1 month post infarct (92). After transient ischemia, treatment
with growth factor restores memory function in the Morris water
maze task, at 49–53 days after surgery, which positively correlates
with the effect of the growth factor on the regeneration of new
neurons (92).
After global ischemia, this is associated with improved spa-
tial learning and memory functions, as assessed using a water
maze (93). Alternatively, Plamondon and Khan (94) suggest that
ischemia-affected rodents do not have habituation deficits at all,
but rather that the testing periods often employed are not long
enough to allow the animal enough time to become familiar with
its environment (94).
In the present study, extensive tissue damage in the somatosen-
sory cortex following the MCAo surgery may have contributed
to the changes in locomotory behaviors, as pyramidal neurons of
the second and third layers of the somatosensory cortex project
to the motor cortex (29, 95). Additionally, previous research has
associated amygdala damage with a decreased anxiety response
that has also been associated with increased exploratory activity
(96). While extensive damage was seen in the amygdala of MCAo
affected animals in the present study (data not shown), the cur-
rent results do not suggest that MCAo operated animals showed
less anxiety-like behaviors in the free exploration test than sham
operated animals. Additionally, we found a negative correlation
between both the number of emergences from the hide box into
the open field, the time spent moving around in the open field and
the percentage of emergence time spent in the center of the open-
field arena, indicating that the change in locomotion is unlikely to
result from a change in anxiety-like behaviors in surgery affected
animals.
We found no obvious difference in the exploration time of the
novel object between basal diets fed MCAo and sham operated
animals. One interpretation is that MCAo surgery does not pre-
vent the beneficial effect of n-3-LC-PUFA supplementation on
the exploration behavior of a novel object, or that the positive
effect of n-3-LC-PUFAs on novel object exploration behavior may
be independent of MCAo. Our findings are consistent with pre-
vious research demonstrating that anti-depressive interventions,
such as electroconvulsive treatment, increase novel objects explo-
ration, in the rodent model (97). However, it should be noted that
in the present study, post hoc tests showed no difference between
MCAo and sham operated animals, in the percentage of emergence
time spent in the center of an open-field arena. The finding that
MCAo operated animals explored the novel object less than sham
operated animals is consistent with previous research indicating
that stressful interventions (conditions of unpredictable chronic
stress) induces sickness behavior and inhibit novel object explo-
ration (98). Interestingly, genetically knocking-out the depression
associated dopamine D4 receptor in mice has also been shown to
be associated with less approach/explore behaviors in the novel
object exploration test (44).
A limitation of the present research is that we did not investigate
serum or vascular EPA and DHA levels. Previously, EPA adminis-
tration post MCAo has been shown to improve local cerebral blood
flow and metabolism in the rat when administered for 4 weeks via
gavage (99). Serum and vasculature tissue have been shown to
be more readily responsive to dietary EPA/DHA supplementation
than brain tissue (100, 101). Thus it is possible that the behav-
ioral effects of n-3-LC-PUFA dietary supplementation may relate
to the effects of PUFA supplementation on cerebral blood flow.
The present findings also indicate an increased reperfusion related
hemorrhagic risk in MCAo n-3-LC-PUFA supplemented rats, after
only a short acclimation period. Further research is required to
clarify the potential risks of n-3-LC-PUFA supplementation on
hemorrhagic bleeding in vulnerable populations. In surviving ani-
mals, n-3-LC-PUFA supplementation appears to reduce surgery
associated hyperactive locomotor and affective symptomology.
In summary, we initially aimed to investigate effects of n-3-LC-
PUFA supplementation on surgery induced acute and longer-term
sickness behaviors, acute motor impairment and anxiety-like and
locomotor behaviors. However, we were surprised to find an
increased risk of hemorrhage following the reperfusion compo-
nent of the surgery, in a number of MCAo n-3-LC-PUFA supple-
mented rats. While these findings appear novel in the context of
experimental MCAo, they are consistent with the effect of n-3-LC-
PUFA supplementation prior to experimental intracerebral hem-
orrhage and the role of omega-3 fatty acids in reducing vasocon-
striction and thus increasing blood flow, after subarachnoid hem-
orrhage. In the present study, PUFA supplementation was not seen
to influence infarct size at 6 weeks after surgery, in animals that did
not experience hemorrhagic bleeding. n-3-LC-PUFA supplemen-
tation did decrease omega-6-fatty-acid expression, reduce sickness
behaviors, acute motor impairment, and longer-term locomo-
tor hyperactivity and depression/anxiety-like behavior. Thus, in
MCAo affected rats, n-3-LC-PUFA supplementation appears to
be associated with both beneficial and detrimental effects. The
current data should be interpreted with caution as we were unable
to prepare the tissue for further experimental analysis, and thus
further research is required to better understand the risks of
n-3-LC-PUFA supplementation in experimental MCAo.
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